Content area
Full Text
Two men developed late-onset neutropenia and leucopenia while receiving rituximab [routes not stated].
A 56-year-old man* had a history of rheumatoid arthritis (RA). He experienced secondary failure to etanercept, and he started receiving an RA protocol with rituximab 1000mg twice in 6 months. He received five courses without adverse events; however, 2 months after his last treatment, he was hospitalised with general weakness and a systemic fever of 39.0°C. He had a WBC count of 350 cells in mm3...